{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T08:08:26Z","timestamp":1784448506655,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]},{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]},{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]},{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]},{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]},{"name":"Hainan Province Clinical Medical Center","award":["20A200217"],"award-info":[{"award-number":["20A200217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Ciprofol is a novel intravenous sedative and anesthetic. Studies have shown that it features a rapid onset of action, a fast recovery time, slight inhibition of respiratory and cardiovascular functions, and a low incidence of adverse reactions. This study aims to explore the median effective dose (ED\n                      <jats:sub>50<\/jats:sub>\n                      ) and the 95% effective dose (ED\n                      <jats:sub>95<\/jats:sub>\n                      ) of ciprofol in inhibiting responses to gastroscope insertion when combined with a low dose of alfentanil, and to evaluate its safety, to provide a reference for the rational use of ciprofol in clinical practices.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We included 25 patients aged 18\u201364\u00a0years of either sex who underwent gastroscopy under intravenous general anesthesia, with a Body Mass Index (BMI) 18\u201328\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , and an American Society of Anesthesiologists (ASA) grade I or II. In this study, the dose-finding strategy of ciprofol followed a modified Dixon\u2019s up-and-down method with an initial dose of 0.30\u00a0mg\/kg and an increment of 0.02\u00a0mg\/kg. Ciprofol was administered after intravenous injection of 7\u00a0\u00b5g\/kg of alfentanil, and 2\u00a0min later a gastroscope was inserted. When the insertion response of one participant was positive (including body movement, coughing, and eye opening), an escalation of 0.02\u00a0mg\/kg would be given to the next participant; otherwise, a de-escalation of 0.02\u00a0mg\/kg would be administered. The study was terminated when negative response and positive response alternated 8 times. A Probit model was used to calculate the ED\n                      <jats:sub>50<\/jats:sub>\n                      and ED\n                      <jats:sub>95<\/jats:sub>\n                      of ciprofol in inhibiting responses to gastroscope insertion when combined with alfentanil. Patients\u2019 recovery time, discharge time, vital signs and occurrence of adverse reactions were recorded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ED\n                      <jats:sub>50<\/jats:sub>\n                      of single-dose intravenous ciprofol injection with 7\u00a0\u00b5g\/kg of alfentanil in inhibiting gastroscope insertion responses was 0.217\u00a0mg\/kg, and the ED\n                      <jats:sub>95<\/jats:sub>\n                      was 0.247\u00a0mg\/kg. Patients\u2019 recovery time and discharge time were 11.04\u2009\u00b1\u20091.49\u00a0min and 9.64\u2009\u00b1\u20092.38\u00a0min, respectively. The overall incidence of adverse reactions was 12%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The ED\n                      <jats:sub>50<\/jats:sub>\n                      of ciprofol combined with 7\u00a0\u00b5g\/kg of alfentanil in inhibiting gastroscope insertion responses was 0.217\u00a0mg\/kg, and the ED\n                      <jats:sub>95<\/jats:sub>\n                      was 0.247\u00a0mg\/kg. Ciprofol showed a low incidence of anesthesia-related adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">http:\/\/www.chictr.org.cn<\/jats:ext-link>\n                      (ChiCTR2200061727).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-023-02387-4","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T01:02:37Z","timestamp":1704157357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effective doses of ciprofol combined with alfentanil in inhibiting responses to gastroscope insertion, a prospective, single-arm, single-center study"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaoru","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangyuanmeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"9","key":"2387_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrgastro.2011.122","volume":"8","author":"M M\u00fcller","year":"2011","unstructured":"M\u00fcller M, Wehrmann T. How best to approach endoscopic sedation? Nat Rev Gastroenterol Hepatol. 2011;8(9):481\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"2387_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic MM, Struys M, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"111047","DOI":"10.1016\/j.jclinane.2022.111047","volume":"85","author":"J Zhong","year":"2023","unstructured":"Zhong J, Zhang J, Fan Y, Zhu M, Zhao X, Zuo Z, Zhou X, Miao C. Efficacy and safety of Ciprofol for procedural sedation and anesthesia in non-operating room settings. J Clin Anesth. 2023;85:111047.","journal-title":"J Clin Anesth"},{"issue":"3","key":"2387_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40263-021-00890-1","volume":"36","author":"Z Luo","year":"2022","unstructured":"Luo Z, Tu H, Zhang X, Wang X, Ouyang W, Wei X, Zou X, Zhu Z, Li Y, Shangguan W, Wu H, Wang Y, Guo Q. Efficacy and safety of HSK3486 for anesthesia\/sedation in patients undergoing fiberoptic bronchoscopy: a multicenter, double-blind, propofol-controlled, randomized, phase 3 study. CNS Drugs. 2022;36(3):301\u201313.","journal-title":"CNS Drugs"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.ejps.2021.105904","volume":"164","author":"Y Teng","year":"2021","unstructured":"Teng Y, Ou M, Wang X, Zhang W, Liu X, Liang Y, Li K, Wang Y, Ouyang W, Weng H, Li J, Yao S, Meng J, Shangguan W, Zuo Y, Zhu T, Liu B, Liu J. Efficacy and safety of ciprofol for the sedation\/anesthesia in patients undergoing colonoscopy: phase IIa and IIb multi-center clinical trials. Eur J Pharm Sci. 2021;164:105904.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2387_CR6","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1213\/ANE.0000000000005570","volume":"133","author":"G Ludbrook","year":"2021","unstructured":"Ludbrook G, Li F, Sleigh J, Liang Y. Assessments of onset and duration of drug effects and pharmacokinetics by dose level of HSK3486, a new sedative-hypnotic agent, in healthy female\/male subjects: a phase I multiarm randomized controlled clinical trial: retraction. Anesth Analg. 2021;133(1):e16.","journal-title":"Anesth Analg"},{"issue":"1","key":"2387_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bcp.14363","volume":"87","author":"Y Bian","year":"2021","unstructured":"Bian Y, Zhang H, Ma S, Jiao Y, Yan P, Liu X, Ma S, Xiong Y, Gu Z, Yu Z, Huang C, Miao L. Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects. Br J Clin Pharmacol. 2021;87(1):93\u2013105.","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"2387_CR8","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1021\/acs.jmedchem.7b01133","volume":"60","author":"Y Wei","year":"2017","unstructured":"Wei Y, Qiu G, Lei B, Qin L, Chu H, Lu Y, Zhu G, Gao Q, Huang Q, Qian G, Liao P, Luo X, Zhang X, Zhang C, Li Y, Zheng S, Yu Y, Tang P, Ni J, Yan P, Zhou Y, Li P, Huang X, Gong A, Liu J. Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle. J Med Chem. 2017;60(20):8580\u201390.","journal-title":"J Med Chem"},{"issue":"2","key":"2387_CR9","first-page":"129","volume":"41","author":"J Liu","year":"2021","unstructured":"Liu J, Wang DX, Zuo YX, Mi WD, Yao SL, Yu WF. Guidelines on clinical application of ciprofol. Chin J Anesthesiol. 2021;41(2):129\u201332.","journal-title":"Chin J Anesthesiol"},{"issue":"5","key":"2387_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/den.13050","volume":"30","author":"SW Yoon","year":"2018","unstructured":"Yoon SW, Choi GJ, Lee OH, Yoon IJ, Kang H, Baek CW, Jung YH, Woo YC. Comparison of propofol monotherapy and propofol combination therapy for sedation during gastrointestinal endoscopy: A systematic review and meta-analysis. Dig Endosc. 2018;30(5):580\u201391.","journal-title":"Dig Endosc"},{"issue":"5","key":"2387_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/ALN.0000000000002138","volume":"128","author":"M Roozekrans","year":"2018","unstructured":"Roozekrans M, van der Schrier R, Aarts L, Sarton E, van Velzen M, Niesters M, Dahan A, Olofsen E. Benefit versus severe side effects of opioid analgesia: novel utility functions of probability of analgesia and respiratory depression. Anesthesiology. 2018;128(5):932\u201342.","journal-title":"Anesthesiology"},{"issue":"1","key":"2387_CR12","first-page":"46","volume":"38","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, Zhou XH, Chen J, Zhang Z, Chen MH, Quan J, Lai DY, Hu TX. Effects of different doses of alfentanil combined with propofol on painless gastroscopy. J Clin Anesthesiol. 2022;38(1):46\u201351.","journal-title":"J Clin Anesthesiol"},{"issue":"2","key":"2387_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.gie.2017.07.018","volume":"87","author":"DS Early","year":"2018","unstructured":"Early DS, Lightdale JR, Vargo JJ 2nd, Acosta RD, Chandrasekhara V, Chathadi KV, Evans JA, Fisher DA, Fonkalsrud L, Hwang JH, Khashab MA, Muthusamy VR, Pasha SF, Saltzman JR, Shergill AK, Cash BD, DeWitt JM. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87(2):327\u201337.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2387_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","volume":"15","author":"WJ Dixon","year":"1991","unstructured":"Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15(1):47\u201350.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2387_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bja.2018.03.037","volume":"121","author":"J Hayes","year":"2018","unstructured":"Hayes J, Matava C, Pehora C, El-Beheiry H, Jarvis S, Finkelstein Y. Determination of the median effective dose of propofol in combination with different doses of ketamine during gastro-duodenoscopy in children: a randomised controlled trial. Br J Anaesth. 2018;121(2):453\u201361.","journal-title":"Br J Anaesth"},{"issue":"6","key":"2387_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bja.2018.01.041","volume":"120","author":"JY Liou","year":"2018","unstructured":"Liou JY, Ting CK, Teng WN, Mandell MS, Tsou MY. Adaptation of non-linear mixed amount with zero amount response surface model for analysis of concentration-dependent synergism and safety with midazolam, alfentanil, and propofol sedation. Br J Anaesth. 2018;120(6):1209\u201318.","journal-title":"Br J Anaesth"},{"issue":"1","key":"2387_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12876-022-02549-7","volume":"22","author":"D Yamaguchi","year":"2022","unstructured":"Yamaguchi D, Morisaki T, Sakata Y, Mizuta Y, Nagatsuma G, Inoue S, Shimakura A, Jubashi A, Takeuchi Y, Ikeda K, Tanaka Y, Yoshioka W, Hino N, Ario K, Tsunada S, Esaki M. Usefulness of discharge standards in outpatients undergoing sedative endoscopy: a propensity score-matched study of the modified post-anesthetic discharge scoring system and the modified Aldrete score. BMC Gastroenterol. 2022;22(1):445.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"2387_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O\u2019Neal PV, Keane KA, Tesoro EP, Elswick RK. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2387_CR19","first-page":"585","volume":"44","author":"FN Hung","year":"2023","unstructured":"Hung FN, Xu C, Cui SS, Xia ZY, Lei SQ. Comparison of anesthetic effects between ciprofol alone and combined with low\u2043dose sufentanil in painless gastroscopy. J Wuhan Univ (Medical Edition). 2023;44(5):585\u20139.","journal-title":"J Wuhan Univ (Medical Edition)"},{"issue":"5","key":"2387_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/00000542-200511000-00017","volume":"103","author":"N Kanaya","year":"2005","unstructured":"Kanaya N, Gable B, Wickley PJ, Murray PA, Damron DS. Experimental conditions are important determinants of cardiac inotropic effects of propofol. Anesthesiology. 2005;103(5):1026\u201334.","journal-title":"Anesthesiology"},{"issue":"6","key":"2387_CR21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1213\/01.ANE.0000087043.61777.1F","volume":"97","author":"T Nagakawa","year":"2003","unstructured":"Nagakawa T, Yamazaki M, Hatakeyama N, Stekiel TA. The mechanisms of propofol-mediated hyperpolarization of in situ rat mesenteric vascular smooth muscle. Anesth Analg. 2003;97(6):1639\u201345.","journal-title":"Anesth Analg"},{"issue":"07","key":"2387_CR22","first-page":"712","volume":"38","author":"QL Yi","year":"2022","unstructured":"Yi QL, Mo HZ, Hu H, Xiang M. Comparison of ciprofol and propofol in elderly patients undergoing gastroscopy. J Clin Anesth. 2022;38(07):712\u20135.","journal-title":"J Clin Anesth"},{"issue":"4","key":"2387_CR23","first-page":"172","volume":"69","author":"RA Martinez","year":"2020","unstructured":"Martinez RA, Hurff A, DeGeorge KC, DeGeorge BR Jr. How to minimize the pain of local anesthetic administration. J Fam Pract. 2020;69(4):172\u20138.","journal-title":"J Fam Pract"},{"issue":"9","key":"2387_CR24","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1002\/jps.23195","volume":"101","author":"MP McIntosh","year":"2012","unstructured":"McIntosh MP, Rajewski RA. Comparative canine pharmacokinetics-pharmacodynamics of fospropofol disodium injection, propofol emulsion, and cyclodextrin-enabled propofol solution following bolus parenteral administration. J Pharm Sci. 2012;101(9):3547\u201352.","journal-title":"J Pharm Sci"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"d1110","DOI":"10.1136\/bmj.d1110","volume":"342","author":"L Jalota","year":"2011","unstructured":"Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, Pace NL, Apfel CC. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;342:d1110.","journal-title":"BMJ"},{"issue":"11","key":"2387_CR26","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1345\/aph.1M290","volume":"43","author":"GD Moore","year":"2009","unstructured":"Moore GD, Walker AM, MacLaren R. Fospropofol: a new sedative-hypnotic agent for monitored anesthesia care. Ann Pharmacother. 2009;43(11):1802\u20138.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2387_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","volume":"107","author":"NL Pace","year":"2007","unstructured":"Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007;107(1):144\u201352.","journal-title":"Anesthesiology"},{"issue":"1","key":"2387_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12871-022-01788-1","volume":"22","author":"TY Zhao","year":"2022","unstructured":"Zhao TY, Chen D, Sun H, Xu ZX, Lyu S, Wang T, Liu LL. Moderate sedation with single-dose remimazolam tosilate in elderly male patients undergoing transurethral resection of the prostate with spinal anesthesia: a prospective, single-arm, single-centre clinical trial. BMC Anesthesiol. 2022;22(1):247.","journal-title":"BMC Anesthesiol"},{"key":"2387_CR29","doi-asserted-by":"publisher","first-page":"735700","DOI":"10.3389\/fphar.2021.735700","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Yang D, Li Q, Wang H, Wang M, Yan P, Wu N, Li F, Ma S, Ding Y, Liu J, Wang H. Safety, pharmacokinetics, and pharmacodynamics of a single bolus of the \u03b3-aminobutyric acid (GABA) receptor potentiator HSK3486 in healthy Chinese elderly and non-elderly. Front Pharmacol. 2021;12:735700.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2387_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/bja\/86.2.183","volume":"86","author":"J Vuyk","year":"2001","unstructured":"Vuyk J, Oostwouder CJ, Vletter AA, Burm AG, Bovill JG. Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br J Anaesth. 2001;86(2):183\u20138.","journal-title":"Br J Anaesth"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02387-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:04:00Z","timestamp":1704197040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02387-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3293210\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the Second Affiliated Hospital of Hainan Medical University (reference number LW202051) and registered at\u00a0\n                      \n                      \u00a0(ChiCTR2200061727). The study protocol followed relevant guidelines. The trail was conducted in accordance with the principles of the Institutional Research Board of the authorized hospital. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}